Review Note

Last Update: 02/18/2024 05:30 AM

Current Deck: Part 2::3. Pathology::Immunohistochemistry

Published

Currently Published Content


Front
Path | IHC | Ovary / testis | GCT | Seminoma / dysgerminoma (and embryonal carcinoma) | OCT 3/4
Back
Summary:
  • Marker of germ cells.
  • Positive in seminoma / dysgerminoma
  • Positive in embryonal carcinoma
  • Negative in other testicular/ovarian GCTs: yolk sac, teratoma, choriocarcinoma
Function:
  • Marker of germ cells, not expressed in somatic tissues
  • Strong, diffuse nuclear expression seen in seminoma/dysgerminoma and embryonal carcinoma
  • Can be expressed focally in advacned epithelial and lymphatic malignancy
Use by pathologists
  • Makrer fro primary adn metastatic germ cell derived tumours of the ovary and extragonadal sites
  • Highly sensitive and specific for primary intracranial germinomas
Positive staining (disease)
  • Seminoma, dysgerminoma (100%)
  • Embryonal caricnoma (100%)
  • Other ovarian tumours
    • Serous adenocarcinoma (90%)
    • Mucinous adenocarcinoma (60%)
Negative staining
  • Yolk sac tumour
  • Teratoma (mature and immature)
  • Choriocarcinoma
  • Sertoli-Leydig cell tumour
  • Granulosa cell tumour
  • Other non-germ cell derived testicular tumours
Further information, not for memorising (no card)
Exam

No published tags.

Pending Suggestions


No pending suggestions for this note.